Semicompeting risks in aging research: methods, issues and needs

Lifetime Data Analysis

Volumn 20, Issue 4, 2014, Pages 538-562

  Varadhan, Ravi ^a   Xue, Qian Li ^a   Bandeen Roche, Karen ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Causal inference; Competing risks; Informative censoring; Multi state models; Potential failure times; Semicompeting processes

Indexed keywords

AGED; AGING; HUMAN; LIFE TABLE; MORBIDITY; RISK; RISK FACTOR; STATISTICAL MODEL;

AGED; AGING; HUMANS; LIFE TABLES; MODELS, STATISTICAL; MORBIDITY; RISK; RISK FACTORS;

EID: 84939897720     PISSN: 13807870     EISSN: 15729249     Source Type: Journal    
DOI: 10.1007/s10985-014-9295-7     Document Type: Article

References (58)

1. Aalen OO (1994) Effects of frailty in survival analysis. Stat Methods Med Res 3:227–243
2. Bandeen-Roche K, Liang KY (2002) Modelling multivariate failure time associations in the presence of a competing risk. Biometrika 89:299–314
3. Boyd CM, Fortin M (2010) Future of multimorbidity research: how should understanding of multimorbidity inform health system design? Public Health Rev 32:451–474
4. Cappola AR, O’Meara ES, Guo W, Bartz TM, Fried LP, Newman AB (2009) Trajectories of dehydroepiandrosterone sulfate predict mortality in older adults: the cardiovascular health study. J Gerontol Med Sci 64:1268–1274
5. Chen Y-H (2012) Maximum likelihood analysis of semicompeting risks data with semiparametric regression models. Lifetime Data Anal 18:36–57
6. Cheng Y, Fine JP (2008) Nonparametric estimation of cause-specific cross hazard ratio with bivariate competing risks data. Biometrika 95:233–40.
7. Cheng Y, Fine JP, Kosorok MR (2007) Nonparametric association analysis of bivariate competing-risks data. J Am Stat Assoc 102:1407–1415
8. Day R, Bryant J, Lefkopoulou M (1997) Adaptation of bivariate frailty models for prediction, with application to biological markers as prognostic indicators. Biometrika 84:45–56
9. Ding AA, Shi G, Wang W, Hsieh J-J (2009) Marginal regression analysis for semi-competing risks data under dependent censoring. Scand J Stat 36:481–500
10. Elashoff RM, Li G, Li N (2007) An approach to joint analysis of longitudinal measurements and competing risks failure time data. Stat Med 26:2813–2835
11. Elashoff RM, Li G, Li N (2008) A joint model for longitudinal measurements and survival data in the presence of multiple failure types. Biometrics 64:762–771
12. Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509
13. Fine JP, Jiang H, Chappell R (2001) On semi-competing risks data. Biometrika 88:907–919
14. Fix E, Neyman J (1951) A simple stochastic model to recovery, relapse, death and loss of patients. Hum Biol 23:204–241
15. Frangakis CE, Rubin DB, An M-W, Mackenzie E (2007) Principal stratification designs to estimate input data missing due to death. Biometrics 63:641–662
16. Fries JF (1980) Aging, natural death, and the compression of morbidity. N Engl J Med 303:1369–1370
17. Gulati R (2011) what if i don’t treat my psa-detected prostate cancer? Answers from three natural history models. Cancer Epidemiol Biomark Prev 55:3–24
18. Henderson R, Diggle P, Dobson A (2000) Joint modelling of longitudinal measurements and event time data. Biostatistics 1:465–480
19. Hernan MA, Alonso A, Logroscino G (2008) Cigarette smoking and dementia: potential selection bias in the elderly. Epidemiology 19:448–450
20. Hernan MA (2010) The hazards of hazard ratios. Epidemiology 21:13–15
21. Hougaard P (1999) Multi-state models: a review. Lifetime Data Anal 5:239–264
22. Hsieh J-J, Huang Y-T (2012) Regression analysis based on conditional likelihood approach under semi-competing risks data. Lifetime Data Anal 103:302320
23. Hu W, Li G, Li N (2009) A bayesian approach to joint analysis of longitudinal measurements and competing risks failure time data. Stat Med 28:1601–1619
24. Kaplan GA, Haan MN, Wallace RB (1999) Understanding changing risk factor associations with increasing age in adults. Annu Rev Public Health 20:89–108
25. Lakhal L, Rivest LP, Abdous B (2008) Estimating survival and association in a semicompeting risks model. Biometrics 64:180–188
26. Larson MG, Dinse GE (1985) A mixture model for the regression-analysis of competing risks data. Appl Stat J R Stat Soc Ser C 34:201–211
27. Li N, Elashoff RM, Li G, Saver J (2010) Joint modeling of longitudinal ordinal data and competing risks survival times and analysis of the ninds rt-pa stroke trial. Stat Med 29:546–557
28. Lin DY, Robins JM, Wei LJ (1996) Comparing two failure time distributions in the presence of dependent censoring. Biometrika 83:381–393
29. Lin OS, Kozarek RA, Schembre DB et al (2006) Screening colnoscopy in very elderly patients: prevalence of neoplasia and estimated impact on life expectancy. JAMA 295:2357–2365
30. Marengoni A, Angleman S, Melis R et al (2011) Aging with multimorbidity: a systematic review of the literature. Aging Res Rev 10:430–439
31. Ng SK, McLachlan GJ (2003) An em-based semi-parametric mixture model approach to the regression analysis of competing-risks data. Stat Med 22:1097–1111
32. Peng L, Fine JP (2006) Rank estimation of accelerated lifetime models with dependent censoring. J Am Stat Assoc 101:1085–1093
33. Peng L, Fine JP (2007) Regression modeling of semicompeting risks data. Biometrics 63:96–108
34. Peterson AV Jr (1976) Bounds for a joint distribution function with fixed sub-distribution functions: application to competing risks. Proc Natl Acad Sci 73:11–13
35. Peterson B, Harrell FE (1990) Partial proportional odds models for ordinal response variables. Appl Stat J R Stat Soc Ser C 39:205–217
36. Prentice RL, Kalbfleisch JD, Peterson AV Jr, Flournoy N, Farewell VT, Breslow NE (1978) The analysis of failure times in the presence of competing risks. Biometrics 34:541–554
37. Putter H (2011) Special issue about competing risks and multi-state models. J Stat Softw 38:1–4
38. Rantanen T, Guralnik JM, Foley D, Masaki K, Leveille S, Curb JD, White L (1999) Midlife hand grip strength as a predictor of old age disability. JAMA 281:558–560
39. Robins JM (1987) A new approach to causal inference in mortality studies with sustained exposure periods—application to control of the healthy worker survivor effect. Comput Mathl Appl 14:923–945
40. Robins JM (1995a) An analytic method for randomized trials with informative censoring: part i. Lifetime Data Anal 1:241–254
41. Robins JM (1995b) An analytic method for randomized trials with informative censoring: part ii. Lifetime Data Anal 1:417–434
42. Scheike TH, Zhang M-J (2008) Flexible competing risks regression modeling and goodness-of-fit. Lifetime Data Anal 14:464–483
43. Scheike TH, Sun Y, Zhang MJ, Jensen TK (2010) A semiparametric random effects model for multivariate competing risks data. Biometrika 97:133–145
44. Shih JH, Albert PS (2010) Modeling familial association of ages at onset of disease in the presence of competing risk. Biometrics 66:1012–1023
45. Slud EV, Rubinstein LV (1983) Dependent competing risks and summary survival curves. Biometrika 70:643–649
46. Tsiatis A (1975) A nonidentifiability aspect of the problem of competing risks. Proc Natl Acad Sci 72:20–22
47. Varadhan R, Weiss CO, Segal JB, Wu AW, Scharfstein D, Boyd C (2010) Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications. Med Care 48:96–105
48. Vaupel JW, Yashin AI (1985) Heterogeneitys ruses: some surprising effects of selection on population dynamics. Am Stat 39:176–185
49. Walter LC, Bertenthal D, Lindquist K, Konety BR (2006) Psa screening among elderly men with limited life expectancies. J Am Med Assoc 296:2336–2342
50. Walter LC, Covinsky KE (2001) Cancer screening in elderly patients: a framework for individualized decision making. J Am Med Assoc 285:2750–2756
51. Wang W (2003) Estimating the association parameter for copula models under dependent censoring. J R Stat Soc 65:257–274
52. Weiss CO, Segal JB, Varadhan R (2012) Assessing the applicability of trial evidence to a target sample in the presence of heterogeneity of treatment effect. Pharmacoepidemiol Drug Saf 21:121–129
53. Welch HG, Albertsen PC, Nease RF, Bubolz TA, Wasson JH (1996) Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med 124:577–584
54. Xu J, Kalbfeisch JD, Tai B (2010) Statistical analysis of illness-death processes and semicompeting risks data. Biometrics 66:716–725
55. Xue QL, Walston JD, Fried LP, Beamer BA (2011) Rate of decline in grip strength predicts the risk of falling, physical disability, and frailty: the womens health and aging study. Arch Intern Med 171:1119–1121
56. Xue QL, Beamer BA, Chaves PHM, Guralnik JM, Fried LP (2010) Heterogeneity in rate of decline in grip, hip, and knee strength and the risk of all-cause mortality: the women’s health and aging study ii. J Am Geriatr Soc 58:2076–2084
57. Yu B, Ghosh P (2010) Joint modeling for cognitive trajectory and risk of dementia in the presence of death. Biometrics 66:294–300
58. Zhang JL, Rubin DB (2003) Estimation of causal effects via principal stratification when some outcomes are truncated by death. J Educ Behav Stat 28:353–368